The portability, flexibility and simplicity of the DIMI system facilitates dialysis in a wide variety of settings including hospitals, clinics, and skilled nursing facilities.

DIMI is indicated to treat patients with acute and/or chronic renal failure with or without fluid overload using hemodialysis (“HD”), hemodiafiltration (“HDF”), hemofiltration (“HF”) and/or ultrafiltration (“UF”) in hospital or clinical settings.

DIMI has Health Canada Approval.
The DIMI System has regulatory approval in the USA (cleared by FDA under 510(k) No. K193005). Dialco is actively seeking FDA approval for home hemodialysis (“HHD”) and peritoneal dialysis (“PD”) use.
DIMI has been developed and is manufactured and commercialized in partnership with Infomed SA.

Dialco & Infomed partnership
Hemodialysis at home
DIMI HHD Home Hemodialysis Unit
DIMI HHD Bag Storage

DIMI Home Hemodialyisis

The portability, flexibility, and simplicity of the DIMI system.

Cappuccino with Claudio Ronco

39th Vicenza Course on Acute Kidney Injury (AKI) and Continuous Renal Replacement Therapy (CRRT) October 2021

CRRT Technology Update
Host: Dr. Claudio Ronco; Guest: Dr. John Kellum and SAMI

Cappuccino with Claudio Ronco

Dr. Ronco introduces the DIMI machine at the ERA-EDTA Nephrology Congress in Budapest, June 2019.